Equities analysts expect Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to announce $0.19 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have provided estimates for Allscripts Healthcare Solutions’ earnings, with the lowest EPS estimate coming in at $0.18 and the highest estimate coming in at $0.22. Allscripts Healthcare Solutions posted earnings per share of $0.16 in the same quarter last year, which would suggest a positive year over year growth rate of 18.8%. The business is scheduled to announce its next earnings results on Thursday, November 1st.
On average, analysts expect that Allscripts Healthcare Solutions will report full-year earnings of $0.75 per share for the current financial year, with EPS estimates ranging from $0.70 to $0.80. For the next year, analysts anticipate that the company will report earnings of $0.85 per share, with EPS estimates ranging from $0.74 to $0.97. Zacks’ EPS calculations are a mean average based on a survey of research analysts that that provide coverage for Allscripts Healthcare Solutions.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings results on Thursday, August 2nd. The software maker reported $0.18 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.18. The company had revenue of $525.50 million for the quarter, compared to analysts’ expectations of $536.93 million. Allscripts Healthcare Solutions had a return on equity of 8.26% and a net margin of 0.10%. The firm’s revenue for the quarter was up 23.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.15 earnings per share.
MDRX stock traded down $0.27 during midday trading on Wednesday, hitting $14.13. The stock had a trading volume of 1,527,600 shares, compared to its average volume of 1,814,698. The stock has a market cap of $2.50 billion, a price-to-earnings ratio of 30.49, a PEG ratio of 1.89 and a beta of 1.14. Allscripts Healthcare Solutions has a 52-week low of $10.78 and a 52-week high of $16.13. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 1.41.
Allscripts Healthcare Solutions announced that its board has approved a share repurchase program on Thursday, August 2nd that authorizes the company to repurchase $250.00 million in outstanding shares. This repurchase authorization authorizes the software maker to repurchase up to 11.3% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.
In other news, CFO Dennis Olis sold 25,000 shares of the company’s stock in a transaction on Thursday, August 16th. The stock was sold at an average price of $14.50, for a total transaction of $362,500.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Brian Farley sold 6,000 shares of the company’s stock in a transaction on Friday, September 14th. The shares were sold at an average price of $14.67, for a total value of $88,020.00. Following the transaction, the executive vice president now directly owns 242,673 shares in the company, valued at $3,560,012.91. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.
Several large investors have recently made changes to their positions in MDRX. Comerica Bank lifted its holdings in shares of Allscripts Healthcare Solutions by 3.9% during the first quarter. Comerica Bank now owns 171,766 shares of the software maker’s stock valued at $2,126,000 after purchasing an additional 6,467 shares in the last quarter. Swiss National Bank lifted its holdings in shares of Allscripts Healthcare Solutions by 2.5% during the first quarter. Swiss National Bank now owns 298,700 shares of the software maker’s stock valued at $3,689,000 after purchasing an additional 7,300 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 7.6% during the first quarter. Schwab Charles Investment Management Inc. now owns 1,644,660 shares of the software maker’s stock valued at $20,312,000 after purchasing an additional 116,170 shares in the last quarter. KBC Group NV lifted its holdings in shares of Allscripts Healthcare Solutions by 4.5% during the first quarter. KBC Group NV now owns 249,754 shares of the software maker’s stock valued at $3,084,000 after purchasing an additional 10,693 shares in the last quarter. Finally, Canandaigua National Bank & Trust Co. bought a new position in shares of Allscripts Healthcare Solutions during the first quarter valued at $145,000.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.
Further Reading: Moving Average – How it Helps Investors in Stock Selection
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.